The Oligomerization of Amyloid β-Protein Begins Intracellularly in Cells Derived from Human Brain

• Published in: Biochemistry (Easton) Vol. 39; no. 35; pp. 10831 - 10839
• Main Authors: Walsh, Dominic M, Tseng, Bertrand P, Rydel, Russell E, Podlisny, Marcia B, Selkoe, Dennis J
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 05.09.2000
• Subjects: Amyloid beta-Peptides - cerebrospinal fluid; Amyloid beta-Peptides - metabolism; Amyloid beta-Protein Precursor - biosynthesis; Amyloid beta-Protein Precursor - genetics; Animals; Body Temperature; Cell-Free System - metabolism; Cells, Cultured; Cerebral Cortex - chemistry; Cerebral Cortex - cytology; Cerebral Cortex - metabolism; CHO Cells; Cricetinae; Culture Media, Conditioned - metabolism; Dimerization; Extracellular Space - metabolism; Fetus; Humans; Intracellular Fluid - metabolism; Molecular Weight; Neurons - chemistry; Neurons - metabolism; Sodium Dodecyl Sulfate - metabolism; Transfection
• DOI: 10.1021/bi001048s
• ISSN: 0006-2960

The progressive aggregation and deposition of amyloid β-protein (Aβ) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans. Inhibiting Aβ aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event. Whereas many studies have examined the aggregation of synthetic Aβ peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Aβ at nanomolar levels in cultures of APP-expressing CHO cells [Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol. Chem. 270, 9564−9570 ( ); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602−3611 ( )]. To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Aβ in some subjects. Incubation of CSF or of CHO conditioned medium at 37 °C did not lead to new oligomer formation. This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse−chase experiments suggested that natural Aβ oligomers might first form intracellularly. We therefore searched for and detected intracellular Aβ oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines. These dimers arose intracellularly rather than being derived from the medium by reuptake. The dimers were particularly detectable in neural cells:  the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells. We conclude that the pathogenically critical process of Aβ oligomerization begins intraneuronally.